Company / Financials
Bionano Genomics, Inc. Financials
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$28.5M
FY2025 · -7.4% YoY
Net Income
-$26.4M
FY2025 · +76.4% YoY
Profit Margin
-92.6%
FY2025 · net income / revenue
ROE
-59.4%
FY2025 · return on equity
Total Assets
$73.6M
FY2025
Total Debt
-
FY2025
Equity
$44.4M
FY2025
ROA
-35.9%
FY2025 · return on assets
Statement paths
Metric history
Revenue HistoryTotal revenue from operations$28.5M-7.4% YoYNet Income HistoryProfit after all expenses and taxes-$26.4M+76.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$15.3M-49.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$33.3M+67.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$35.1M-32.2% YoYR&D Expense HistoryResearch and development spending$11.4M-54.1% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$67.0K+103.0% YoYEPS (Basic) HistoryBasic earnings per share-$88.13+78.4% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$88.13+78.4% YoY